Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.750
-0.050 (-2.78%)
At close: Jun 3, 2026, 4:00 PM EDT
1.750
0.00 (0.00%)
After-hours: Jun 3, 2026, 6:26 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.49 million as of June 3, 2026. Its market cap has decreased by -21.29% in one year.
Market Cap
7.49M
Enterprise Value
-1.77M
1-Year Change
-21.29%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.49M, a decrease of -86.92%. That is a compound annual growth rate of -33.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 7.49M | 28.06% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 8.22M |
| Creative Medical Technology Holdings | 8.02M |
| Quoin Pharmaceuticals | 7.99M |
| PharmaCyte Biotech | 7.80M |
| CNS Pharmaceuticals | 7.66M |
| Xenetic Biosciences | 7.65M |
| Genprex | 7.62M |
| Processa Pharmaceuticals | 7.45M |